On Monday, Concentrix earned an upgrade to its Relative Strength (RS) Rating, from 68 to 73.
Can You Really Time The Stock Market?
IBD's proprietary RS Rating tracks technical performance by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research reveals that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 in the early stages of their moves. See if Concentrix can continue to rebound and clear that threshold.
Concentrix is not currently near a potential buy zone. See if the stock goes on to form a base that could spark a new run.
Earnings growth slowed in the most recent report from 3% to 0%. But revenue gains moved higher, from -1% to 2%.
The company earns the No. 29 rank among its peers in the Computer Software-Enterprise industry group. Palantir Technologies, Cloudflare and Shopify are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
